Hyperfine (HYPR) Net Margin (2021 - 2026)

Hyperfine (HYPR) posted Net Margin of 220.93% for Q1 2026, down 97.8% on a QoQ basis from 111.69% in Q4 2025, and up 21978.0% year-over-year from N/an in Q1 2025.

Hyperfine (HYPR) Net Margin (2021 - 2026) Analysis & Trends

Hyperfine's Net Margin history runs 6 years deep, the most recent figure standing at 220.93% for Q1 2026.

  • Quarterly Net Margin rose 21978.0% year-over-year to 220.93% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 226.88% (up 11654.0% YoY) and the FY2025 annual result came in at 262.29%, up 5362.0% from the prior year.
  • Net Margin was 220.93% for Q1 2026 at Hyperfine, down from 111.69% in the prior quarter.
  • Across five years, Net Margin topped out at 111.69% in Q4 2025 and bottomed at 1575.55% in Q1 2022.
  • A 5-year average of 526.21% and a median of 397.77% in 2023 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2022 — Net Margin jumped 506573 bps — and 2025, when it tumbled 14183 bps.
  • Hyperfine's Net Margin stood at 917.06% in 2022, then surged by 57 bps to 397.77% in 2023, then declined by 13 bps to 447.65% in 2024, then surged by 75 bps to 111.69% in 2025, then slumped by 98 bps to 220.93% in 2026.
  • Business Quant data shows HYPR's Net Margin at 220.93% in Q1 2026, 111.69% in Q4 2025, and 320.6% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 9.65%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 12.38%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 12.84%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 16.74%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 3.87%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 8.01%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Hyperfine 92.81 Mn 51.53 Mn 1.98 Mn -220.93%

Historic Data

Download Data
DateValue
Mar 31, 2026 -220.93%
Dec 31, 2025 -111.69%
Sep 30, 2025 -320.60%
Jun 30, 2025 -342.17%
Mar 31, 2025 -440.71%
Dec 31, 2024 -447.65%
Sep 30, 2024 -283.45%
Jun 30, 2024 -279.70%
Mar 31, 2024 -298.88%
Dec 31, 2023 -397.77%
Sep 30, 2023 -461.67%
Jun 30, 2023 -314.61%
Mar 31, 2023 -461.48%
Dec 31, 2022 -917.06%
Sep 30, 2022 -560.95%
Jun 30, 2022 -1,510.70%
Mar 31, 2022 -1,575.55%
Dec 31, 2021 -5,982.80%
Sep 30, 2021 -4,418.33%
Jun 30, 2021 -4,072.63%